Busey Bank’s NeoGenomics NEO Stock Holding History

Busey Bank’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,000	Closed	-$79K	–	187
2017 Q1	$79K	Hold	10,000	–	–	0.01%	186
2016 Q4	$86K	Sell	10,000 -10,000	-50%	-$85.7K	0.01%	195
2016 Q3	$164K	Hold	20,000	–	–	0.02%	187
2016 Q2	$161K	Hold	20,000	–	–	0.02%	191
2016 Q1	$135K	Hold	20,000	–	–	0.02%	194
2015 Q4	$157K	Buy	+20,000	New	+$146K	0.02%	194

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Busey Bank's NEO Position: Q2 2017 in Review

Busey Bank sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 10,000 shares — an estimated $79K sold.

Busey Bank first reported a position in NEO in Q4 2015 and held it in 6 quarters. The position peaked at $164K in Q3 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Busey Bank reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
Busey Bank sold 10,000 NeoGenomics shares in Q2 2017, an estimated $79K.
Busey Bank first reported a position in NeoGenomics in Q4 2015 and held it in 6 quarters.
Busey Bank's NeoGenomics position peaked at $164K in Q3 2016.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Busey Bank's 13F filing for Q2 2017, filed 28 Jul 2017.